CBD maker GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company warned the COVID-19 pandemic could hit sales if fewer patients visit their doctors. Revenue in the quarter ending March 31 reached $120.6 million, up from $91 million and $109.1 […]
GW Pharma trims loss to $8 million, warns virus could hit sales is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
From GW Pharma trims loss to $8 million, warns virus could hit sales on CBD Products & CBD Business News – Hemp Industry Daily.
This was autoposted by IFTTT. To find out more, read my post about news articles.
No comments:
Post a Comment